Stereotactic Radiosurgery and Radiofrequency Surgery

Stereotactic surgery in Israel, including stereotactic radiosurgery and radiofrequency surgery, is a highly advanced, minimally invasive method that delivers targeted radiation beams, such as Gamma Knife, CyberKnife, or linear accelerators, directly to the tumor. The technology destroys the DNA structure within the cancerous cells, stopping tumor growth effectively.

Pioneered by Swedish neurosurgeon Lars Leksell, stereotactic radiosurgery has evolved into a key method for treating brain metastases and primary tumors. The Gamma Knife, first used in 1960, and the CyberKnife, developed by John Adler in 1992, are now integral tools in stereotactic radiosurgery Israel. The CyberKnife is widely used for brain and spinal tumors, head and neck lesions, and other complex cases.

While technology has advanced, the principle remains the same: high-intensity focused radiation is delivered with millimeter precision. Treatments can be single-session, high-dose radiation or multiple sessions (fractions), depending on the case. For secondary brain lesions, radiofrequency surgery in Israel is often used after traditional surgery or as a primary treatment when surgery is not feasible.

During stereotactic surgery in Israel, a stereotactic frame is placed on the patient’s head, followed by MRI or high-resolution CT imaging with contrast. Radiologists analyze the scans to define the exact tumor coordinates, boundaries, and optimal radiation dose. Based on these findings, a tailored treatment plan is developed. The therapy session itself typically lasts between 10 minutes and 1 hour, with most cases completed within a day.

For brain metastases, stereotactic radiosurgery has become a primary treatment method, especially when tumors are located in hard-to-reach areas such as the thalamus or brainstem. The precision of tools like Gamma Knife and CyberKnife enables safe and effective targeting of these lesions. Studies in the United States have demonstrated that patients who receive stereotactic radiosurgery show significantly lower recurrence rates compared to those treated with surgery alone.

• Brain metastases: From lung, breast, colon, kidney cancers, and melanoma.

• Benign brain tumors: Meningiomas, schwannomas (acoustic neuromas), pituitary adenomas.

• Arteriovenous malformations (AVMs): Successfully treated without damaging healthy brain tissue.

• Trigeminal neuralgia: Treated with stereotactic radiosurgery or radiofrequency surgery in Israel using non-invasive techniques like Gamma Knife, often under local anesthesia.

• Spinal tumors: Stereotactic radiofrequency surgery is used for spinal metastases and primary spinal tumors to preserve mobility and prevent paralysis.
  

Most patients undergoing stereotactic radiosurgery in Israel experience minimal side effects and can return to their daily routines within a short period. Strict adherence to medical guidance is essential. Following treatment, ongoing imaging studies such as MRI and CT scans monitor the patient’s condition.

For patients seeking no wait radiosurgery abroad, Israel’s advanced centers offer immediate scheduling without long waiting lists. Stereotactic surgery without waiting is available for international patients, ensuring timely access to cutting-edge treatments like LU177 isotope therapy in Israel for specific cases.

Israel is a global leader in stereotactic surgery and radiofrequency surgery, combining cutting-edge technology, experienced neurosurgeons, and a personalized approach. Whether for brain metastases, primary tumors, AVMs, or trigeminal neuralgia, patients benefit from precise, minimally invasive treatments that preserve quality of life.